Zestoretic (lisinopril dihydrate - hydrochlorothiazide) is a fixed-dose combination of the ACE inhibitor, lisinopril dihydrate, and the diuretic, hydrochlorothiazide, for hypertension.
Zestoretic is in-licensed from Merck & Co., Inc.
Did you know?
AstraZeneca has a range of product specific and disease area websites for international healthcare professionals and patients. Links to this information can be found below.
Links to country-specific websites can be found using the AstraZeneca websites list.
If you still have a question regarding our drug portfolio you can Contact us.
Not signed in
Page tools
Share price
- London
-
26.95 GBP - New York
-
44.82 USD
- Stockholm
-
310.10 SEK
At 21-Nov-2009 09:24 GMT
Detailed share priceIntroduction to AstraZeneca
Our responsibility
We continue to communicate openly on a range of issues, including:
